Abstract
A 52-year-old Japanese woman suffering from AML (FAB classification M4) in her first remission received an autologous peripheral blood stem cell transplant (APBSCT). She was seropositive for CMV prior to APBSCT. Her post-APBSCT course was complicated with CMV-associated disease and hemophagocytic syndrome. Finally, CMV interstitial pneumonia developed and death ensued. Even after APBSCT, there can be a short period of immune deficiency resembling that occurring following allogeneic or autologous BMT. CMV infection must be considered in the differential diagnosis in cases of unexplained fever or pneumonia following APBSCT.
Author information
Affiliations
Consortia
Rights and permissions
About this article
Cite this article
Nagafuji, K., Eto, T., Hayashi, S. et al. Fatal cytomegalovirus interstitial pneumonia following autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 21, 301–303 (1998). https://doi.org/10.1038/sj.bmt.1701069
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1701069
Keywords
- cytomegalovirus
- interstitial pneumonia
- peripheral blood stem cell transplantation
Further reading
-
Etoposide-containing conditioning regimen reduces the occurrence of hemophagocytic lymphohistiocytosis after SCT
Bone Marrow Transplantation (2014)
-
Safety and feasibility of CHOP/rituximab induction treatment followed by high-dose chemo/radiotherapy and autologous PBSC-transplantation in patients with previously untreated mantle cell or indolent B-cell-non-Hodgkin's lymphoma
Bone Marrow Transplantation (2003)
-
CMV infection and pneumonia in hematological malignancies
Journal of Infection and Chemotherapy (2003)
-
Rituximab in vivo purging is safe and effective in combination with CD34-positive selected autologous stem cell transplantation for salvage therapy in B-NHL
Bone Marrow Transplantation (2002)
-
Hemophagocytic syndrome: a rare complication of allogeneic nonmyeloablative hematopoietic stem cell transplantation
Bone Marrow Transplantation (2002)
